AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
1.260
-0.010 (-0.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $37.65 million as of December 20, 2024. Its market cap has decreased by -93.27% in one year.
Market Cap
37.65M
Enterprise Value
-55.78M
1-Year Change
-93.27%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $37.65M, a decrease of -86.61%. That is a compound annual growth rate of -51.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 37.65M | -93.82% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexalin Technology | 39.36M |
| Neuronetics | 39.15M |
| Lexaria Bioscience | 38.57M |
| SCYNEXIS | 38.33M |
| Aileron Therapeutics | 38.13M |
| CalciMedica | 37.34M |
| Envoy Medical | 37.25M |
| Enzo Biochem | 37.22M |